Edap TMS SA (FOCL) FY2025 results: revenue $71 million, up 1.6% on the year
Edap TMS SA (FOCL) reported revenue of $71 million for fiscal 2025, the year ended 31 December 2025, up 1.6% on the year before. Net income was -$29 million, and diluted earnings per share $-0.78. The figures are the company's own, from the 10-K it filed with the SEC on 25 March 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 2 kept.
- Full-year HIFU revenue rose 39%: HIFU business revenue for 2025 was €33.1 million ($37.4 million), up from €23.8 million ($25.8 million) in 2024.
- Full-year total revenue down 3%: Worldwide revenue for 2025 was €62.4 million ($70.5 million), down 3% from €64.1 million ($69.4 million) in 2024, with lower non-core revenue.
- Full-year net loss widened: Net loss was €25.9 million ($29.2 million), or €(0.69) per share, against €19.0 million ($20.6 million), or €(0.51), in 2024.
- Record fourth-quarter system placements: Net system placements in the fourth quarter were 15, described as a quarterly record: 14 cash sales and one operating lease.
- U.S. procedures up 28% in Q4: U.S. Focal One procedures rose 28% year over year in the fourth quarter, the second consecutive quarter of double-digit procedure growth.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2022 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 70.5 | 69.4 | 55.1 | +1.6% | |
| Cost of revenue | 40.5 | 40.7 | n/a | -0.3% | |
| Gross profit | 30.0 | 28.7 | n/a | +4.4% | |
| Gross margin | 42.5% | 41.4% | n/a | ||
| Research and development | 9.7 | 8.4 | n/a | +15.5% | |
| Operating income | -24.7 | -22.2 | n/a | ||
| Operating margin | -35.0% | -32.0% | n/a | ||
| Interest expense | 0.8 | 0.3 | 0.2 | +208.2% | |
| Pre-tax income | -28.8 | -20.3 | n/a | ||
| Income tax | 0.4 | 0.3 | n/a | +39.9% | |
| Net income | -29.2 | -20.6 | n/a | ||
| Net margin | -41.5% | -29.7% | n/a | ||
| Diluted EPS | -$0.78 | -$0.55 | n/a |
$ million except per share.
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2022 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | -16.4 | -14.7 | n/a | ||
| Cash from investing | -5.7 | -4.5 | n/a | ||
| Cash from financing | 8.6 | 5.0 | n/a | +71.7% | |
| Depreciation and amortisation | 3.4 | 2.8 | n/a | +22.7% | |
| Diluted shares, weighted | 37m | 37m | 34m | +0.4% | |
| Shares outstanding at period end | 37m | 37m | 37m | +0.2% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2022 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 19.4 | 42.5 | n/a | -54.3% | |
| Debt | 24.0 | 11.2 | n/a | +113.7% | |
| Operating lease liabilities | 2.1 | 1.6 | n/a | +25.8% | |
| Finance lease liabilities | 0.4 | 0.4 | n/a | -2.5% | |
| Other liabilities | 33.1 | 33.7 | n/a | -1.6% | |
| Total liabilities and equity | 79.0 | 89.4 | n/a | -11.6% | |
| Fixed assets | 9.9 | 7.6 | n/a | +30.6% | |
| Goodwill | 2.8 | 2.5 | n/a | +13.1% | |
| Intangible assets | 1.8 | 1.1 | n/a | +59.4% | |
| Investments | 0.0 | n/a | n/a | ||
| Cash and equivalents | 20.5 | 31.0 | n/a | -34.0% | |
| Receivables | 21.3 | 19.3 | n/a | +10.2% | |
| Inventory | 12.8 | 19.2 | n/a | -33.2% | |
| Other assets | 9.9 | 8.7 | n/a | +14.3% | |
| Total assets | 79.0 | 89.4 | n/a | -11.6% |
10-K for the year ended 31 December 2025, filed 25 March 2026: the filing.